--- title: Newsroom | Pharma (7) description: Pharma | (7) --- [![Life Science Newswire 2](https://news.lifesciencenewswire.com/hs-fs/hubfs/Life%20Science%20Newswire%202.png?width=203&height=60&name=Life%20Science%20Newswire%202.png "Life Science Newswire 2")](https://lifesciencenewswire.com/) - [Newsroom](https://news.lifesciencenewswire.com/newsroom) - [Back to the main site](https://lifesciencenewswire.com/) ![LSNewswire-main-header-banner-v2-1](https://news.lifesciencenewswire.com/hubfs/LSNewswire-main-header-banner-v2-1.jpg "LSNewswire-main-header-banner-v2-1") # Newsroom #### Categories ![Arrow](https://cdn2.hubspot.net/hubfs/3842749/ps4-Pack/sidebar.svg "Arrow") #### Subscribe![](https://cdn2.hubspot.net/hubfs/3842749/ps4-Pack/subscribe-rss-button.svg) ![](https://cdn2.hubspot.net/hubfs/3842749/ps4-Pack/close-button.svg) ### Choose a Category - [Agriculture (1)](https://news.lifesciencenewswire.com/newsroom/tag/agriculture) - [AI (2)](https://news.lifesciencenewswire.com/newsroom/tag/ai) - [Analytical Chemistry (42)](https://news.lifesciencenewswire.com/newsroom/tag/analytical-chemistry) - [Biomanufacturing (35)](https://news.lifesciencenewswire.com/newsroom/tag/biomanufacturing) - [biopharma (23)](https://news.lifesciencenewswire.com/newsroom/tag/biopharma) - [Bioprocessing (16)](https://news.lifesciencenewswire.com/newsroom/tag/bioprocessing) - [Biotechnology (252)](https://news.lifesciencenewswire.com/newsroom/tag/biotechnology) - [Cell Culture (10)](https://news.lifesciencenewswire.com/newsroom/tag/cell-culture) - [Clinical Diagnostics (38)](https://news.lifesciencenewswire.com/newsroom/tag/clinical-diagnostics) - [clinical research (6)](https://news.lifesciencenewswire.com/newsroom/tag/clinical-research) - [Clinical Research & Trials (117)](https://news.lifesciencenewswire.com/newsroom/tag/clinical-research-trials) - [Computing & Technology (62)](https://news.lifesciencenewswire.com/newsroom/tag/computing-it) - [Corporate, Finance & Investor (288)](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor) - [COVID-19 (86)](https://news.lifesciencenewswire.com/newsroom/tag/covid-19) - [Diagnostics & Hospital Laboratory (38)](https://news.lifesciencenewswire.com/newsroom/tag/diagnostics-hospital-laboratory) - [Digital Pathology (2)](https://news.lifesciencenewswire.com/newsroom/tag/digital-pathology) - [Drug Discovery & Development (153)](https://news.lifesciencenewswire.com/newsroom/tag/drug-discovery-development) - [Energy & Environment (15)](https://news.lifesciencenewswire.com/newsroom/tag/energy-environment) - [excipients (1)](https://news.lifesciencenewswire.com/newsroom/tag/excipients) - [Food & Beverage (8)](https://news.lifesciencenewswire.com/newsroom/tag/food-beverage) - [General Chemistry (7)](https://news.lifesciencenewswire.com/newsroom/tag/general-chemistry) - [General Laboratory (58)](https://news.lifesciencenewswire.com/newsroom/tag/general-laboratory) - [General Science (5)](https://news.lifesciencenewswire.com/newsroom/tag/general-science) - [Healthcare (136)](https://news.lifesciencenewswire.com/newsroom/tag/healthcare) - [Hospital Management (7)](https://news.lifesciencenewswire.com/newsroom/tag/hospital-management) - [Life Science (26)](https://news.lifesciencenewswire.com/newsroom/tag/life-science) - [Manufacturing (2)](https://news.lifesciencenewswire.com/newsroom/tag/manufacturing) - [Materials Science (2)](https://news.lifesciencenewswire.com/newsroom/tag/materials-science) - [Medical Devices & Technology (26)](https://news.lifesciencenewswire.com/newsroom/tag/medical-devices-technology) - [Microbiology & Infection Control (18)](https://news.lifesciencenewswire.com/newsroom/tag/microbiology-infection-control) - [Microscopy & Imaging (47)](https://news.lifesciencenewswire.com/newsroom/tag/microscopy-imaging) - [Nanotech (2)](https://news.lifesciencenewswire.com/newsroom/tag/nanotech) - [Omics & Genetics (87)](https://news.lifesciencenewswire.com/newsroom/tag/omics-genetics) - [Pathology (5)](https://news.lifesciencenewswire.com/newsroom/tag/pathology) - [Pharma (118)](https://news.lifesciencenewswire.com/newsroom/tag/pharma) - [Pharmacy (5)](https://news.lifesciencenewswire.com/newsroom/tag/pharmacy) - [Research (47)](https://news.lifesciencenewswire.com/newsroom/tag/research) - [Veterinary (6)](https://news.lifesciencenewswire.com/newsroom/tag/veterinary) - [Water (8)](https://news.lifesciencenewswire.com/newsroom/tag/water) See all ### Subscribe to Email Updates Categories: [Pharma](https://news.lifesciencenewswire.com/newsroom/tag/pharma), [Corporate, Finance & Investor](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor) #### [Society of Toxicology announced ScitoVation’s senior research fellow, Jeffrey W. Fisher, PhD, awarded 2022 SOT Arnold J. Lehman](https://news.lifesciencenewswire.com/newsroom/newsociety-of-toxicology-announced-scitovations-senior-research-fellow-jeffrey-w.-fisher-phd-awarded-2022-sot-arnold-j.-lehman) March 15, 2022 ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/newsociety-of-toxicology-announced-scitovations-senior-research-fellow-jeffrey-w.-fisher-phd-awarded-2022-sot-arnold-j.-lehman) 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/newsociety-of-toxicology-announced-scitovations-senior-research-fellow-jeffrey-w.-fisher-phd-awarded-2022-sot-arnold-j.-lehman#comments-listing) by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Mar 15, 2022, 1:30:00 PM - [Tweet](https://twitter.com/share) Categories: [Analytical Chemistry](https://news.lifesciencenewswire.com/newsroom/tag/analytical-chemistry), [Pharma](https://news.lifesciencenewswire.com/newsroom/tag/pharma) #### [New, innovative GC and GC-MS product portfolio enables greater uptime and efficiency](https://news.lifesciencenewswire.com/newsroom/new-innovative-gc-and-gc-ms-product-portfolio-enables-greater-uptime-and-efficiency) March 8, 2022 ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/new-innovative-gc-and-gc-ms-product-portfolio-enables-greater-uptime-and-efficiency) 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/new-innovative-gc-and-gc-ms-product-portfolio-enables-greater-uptime-and-efficiency#comments-listing) by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Mar 8, 2022, 1:00:00 PM - [Tweet](https://twitter.com/share) Categories: [Pharma](https://news.lifesciencenewswire.com/newsroom/tag/pharma), [Corporate, Finance & Investor](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor) #### [Holo-Blister® is a new anti-counterfeiting system for pharmaceutical blister-packs that has just been awarded patents in both the U.S. and Europe](https://news.lifesciencenewswire.com/newsroom/holo-blister-is-a-new-anti-counterfeiting-system-for-pharmaceutical-blister-packs-that-has-just-been-awarded-patents-in-both-the-u.s.-and-europe) February 23, 2022 ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/holo-blister-is-a-new-anti-counterfeiting-system-for-pharmaceutical-blister-packs-that-has-just-been-awarded-patents-in-both-the-u.s.-and-europe) 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/holo-blister-is-a-new-anti-counterfeiting-system-for-pharmaceutical-blister-packs-that-has-just-been-awarded-patents-in-both-the-u.s.-and-europe#comments-listing) by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Feb 23, 2022, 12:00:00 PM - [Tweet](https://twitter.com/share) Categories: [Pharma](https://news.lifesciencenewswire.com/newsroom/tag/pharma), [Corporate, Finance & Investor](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor) #### [WAPG announces new partnerships with leading firms to secure free tax and legal advisory services for early-stage life sciences and healthcare companies](https://news.lifesciencenewswire.com/newsroom/wapg-announces-new-partnerships-with-leading-firms-to-secure-free-tax-and-legal-advisory-services-for-early-stage-life-sciences-and-healthcare-companies) January 25, 2022 ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/wapg-announces-new-partnerships-with-leading-firms-to-secure-free-tax-and-legal-advisory-services-for-early-stage-life-sciences-and-healthcare-companies) 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/wapg-announces-new-partnerships-with-leading-firms-to-secure-free-tax-and-legal-advisory-services-for-early-stage-life-sciences-and-healthcare-companies#comments-listing) by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Jan 25, 2022, 9:00:00 AM - [Tweet](https://twitter.com/share) Categories: [Pharma](https://news.lifesciencenewswire.com/newsroom/tag/pharma), [Corporate, Finance & Investor](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor) #### [Lonza and NNIT to host free webinar on MES for the future – achieving pharma 4.0 through accelerated MES implementation](https://news.lifesciencenewswire.com/newsroom/lonza-and-nnit-to-host-free-webinar-on-mes-for-the-future-achieving-pharma-4.0-through-accelerated-mes-implementation) January 11, 2022 ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/lonza-and-nnit-to-host-free-webinar-on-mes-for-the-future-achieving-pharma-4.0-through-accelerated-mes-implementation) 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/lonza-and-nnit-to-host-free-webinar-on-mes-for-the-future-achieving-pharma-4.0-through-accelerated-mes-implementation#comments-listing) by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Jan 11, 2022, 4:43:51 PM - [Tweet](https://twitter.com/share) Categories: [Pharma](https://news.lifesciencenewswire.com/newsroom/tag/pharma), [General Chemistry](https://news.lifesciencenewswire.com/newsroom/tag/general-chemistry) #### [Sinocompound and InCatT launch new Catalyst Screening Service collaboration offering accelerated route to market](https://news.lifesciencenewswire.com/newsroom/sinocompound-and-incatt-launch-new-catalyst-screening-service-collaboration-offering-accelerated-route-to-market) January 11, 2022 ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/sinocompound-and-incatt-launch-new-catalyst-screening-service-collaboration-offering-accelerated-route-to-market) 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/sinocompound-and-incatt-launch-new-catalyst-screening-service-collaboration-offering-accelerated-route-to-market#comments-listing) by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Jan 11, 2022, 1:00:00 PM - [Tweet](https://twitter.com/share) Categories: [Pharma](https://news.lifesciencenewswire.com/newsroom/tag/pharma), [Corporate, Finance & Investor](https://news.lifesciencenewswire.com/newsroom/tag/corporate-finance-investor) #### [Inceptua receives approval of marketing authorization transfer of Apealea® (paclitaxel micellar) for the treatment of ovarian cancer](https://news.lifesciencenewswire.com/newsroom/inceptua-receives-approval-of-marketing-authorization-transfer-of-apealea-paclitaxel-micellar-for-the-treatment-of-ovarian-cancer) December 14, 2021 ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/inceptua-receives-approval-of-marketing-authorization-transfer-of-apealea-paclitaxel-micellar-for-the-treatment-of-ovarian-cancer) 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/inceptua-receives-approval-of-marketing-authorization-transfer-of-apealea-paclitaxel-micellar-for-the-treatment-of-ovarian-cancer#comments-listing) by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Dec 14, 2021, 1:00:00 PM - [Tweet](https://twitter.com/share) Categories: [Pharma](https://news.lifesciencenewswire.com/newsroom/tag/pharma), [Medical Devices & Technology](https://news.lifesciencenewswire.com/newsroom/tag/medical-devices-technology) #### [Deplesin® strategic partnerships meet a huge unmet need for bipolar disorder patients, while emphasizing corporate commitments to innovation and increasing partner revenue](https://news.lifesciencenewswire.com/newsroom/deplesin-strategic-partnerships-meet-a-huge-unmet-need-for-bipolar-disorder-patients-while-emphasizing-corporate-commitments-to-innovation-and-increasin-1639413071907) December 14, 2021 ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/deplesin-strategic-partnerships-meet-a-huge-unmet-need-for-bipolar-disorder-patients-while-emphasizing-corporate-commitments-to-innovation-and-increasin-1639413071907) 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/deplesin-strategic-partnerships-meet-a-huge-unmet-need-for-bipolar-disorder-patients-while-emphasizing-corporate-commitments-to-innovation-and-increasin-1639413071907#comments-listing) by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Dec 14, 2021, 11:30:00 AM - [Tweet](https://twitter.com/share) Categories: [Computing & Technology](https://news.lifesciencenewswire.com/newsroom/tag/computing-it), [Pharma](https://news.lifesciencenewswire.com/newsroom/tag/pharma), [Clinical Research & Trials](https://news.lifesciencenewswire.com/newsroom/tag/clinical-research-trials) #### [Formedix launches community forum and resource hub to support clinical trial industry](https://news.lifesciencenewswire.com/newsroom/formedix-launches-community-forum-and-resource-hub-to-support-clinical-trial-industry) December 1, 2021 ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/formedix-launches-community-forum-and-resource-hub-to-support-clinical-trial-industry) 0 Comments [Click here to read/write comments](https://news.lifesciencenewswire.com/newsroom/formedix-launches-community-forum-and-resource-hub-to-support-clinical-trial-industry#comments-listing) by [Life Science Newswire](https://news.lifesciencenewswire.com/newsroom/author/newswire) on Dec 1, 2021, 2:00:00 PM - [Tweet](https://twitter.com/share) [Previous](https://news.lifesciencenewswire.com/newsroom/tag/pharma/page/6) [All posts](https://news.lifesciencenewswire.com/newsroom/all) [Next](https://news.lifesciencenewswire.com/newsroom/tag/pharma/page/8) ##### Browse more news ## Recent releases #### [Ceryx Medical manufactures first implantable heart failure device at King’s College London’s MAISI f...](https://news.lifesciencenewswire.com/newsroom/ceryx-medical-manufactures-first-implantable-heart-failure-device-at-kings-college-londons-maisi-facility) October 22, 2026 A first for both organisations: the first implantable device built by the UK’s national active implant manufacturing facility is Ceryx’s bioelectronic... ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/ceryx-medical-manufactures-first-implantable-heart-failure-device-at-kings-college-londons-maisi-facility) #### [Scope’s CRISPR Molecular Diagnostics CE Marked for Antifungal Resistance](https://news.lifesciencenewswire.com/newsroom/scopes-crispr-molecular-diagnostics-ce-marked-for-antifungal-resistance) October 6, 2026 Developed with AmplexDiagnostics, eazySNP brings scopeDx® into human diagnostics Scope Biosciences B.V., a Wageningen University spinoff life sciences... ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/scopes-crispr-molecular-diagnostics-ce-marked-for-antifungal-resistance) #### [CellCarta Establishes Strategic Partnership with Waters to Advance Companion Diagnostics Development](https://news.lifesciencenewswire.com/newsroom/cellcarta-establishes-strategic-partnership-with-waters-to-advance-companion-diagnostics-development) October 5, 2026 Collaboration combines CellCarta’s global clinical trial testing capabilities with Waters’ standardized flow cytometry platforms and expertise CellCar... ##### [READ MORE](https://news.lifesciencenewswire.com/newsroom/cellcarta-establishes-strategic-partnership-with-waters-to-advance-companion-diagnostics-development) ![LS-Newswire-reverse](https://news.lifesciencenewswire.com/hs-fs/hubfs/raw_assets/public/LifeScienceNewswire_June2020/images/LS-Newswire-reverse.png?width=150&name=LS-Newswire-reverse.png "LS-Newswire-reverse") Life Science Newswire is a division of BioStrata Ltd, with company registered address: 3rd Floor, 1 Ashley Road, Altrincham, Cheshire, England, WA14 2DT. Company registration number: 8233225  #### Useful information - [Cookie and privacy policy](https://lifesciencenewswire.com/cookie-privacy-policy/) - [Website terms and conditions](https://lifesciencenewswire.com/terms-and-conditions) - [Promotion terms and conditions](https://lifesciencenewswire.com/promotion_terms/)